AstraZeneca

AstraZeneca, Daiichi Tout Phase III Breast Cancer Data in Challenge to Gilead
AstraZeneca, Daiichi Tout Phase III Breast Cancer Data in Challenge to Gilead
BioSpace
AstraZeneca
Daiichi Sankyo
breast cancer
antibody-drug conjugate
clinical trials
Flag link:
AstraZeneca refused to pay full bonus to US remote worker, lawsuit claims
AstraZeneca refused to pay full bonus to US remote worker, lawsuit claims
Reuters
AstraZeneca
legal
remote work
employment law
Flag link:
AZ's Alexion inks $125M deal to resolve investor lawsuit over Soliris sales tactics
AZ's Alexion inks $125M deal to resolve investor lawsuit over Soliris sales tactics
Fierce Pharma
Alexion
AstraZeneca
Soliris
investors
legal
Flag link:
AstraZeneca, working to grow Fasenra’s reach, touts positive trial against GSK's Nucala in new use
AstraZeneca, working to grow Fasenra’s reach, touts positive trial against GSK's Nucala in new use
Fierce Pharma
AstraZeneca
Fasenra
clinical trials
GSK
Nucala
eosinophilic asthma
Flag link:
AstraZeneca, Daiichi Sankyo show off ADC portfolio with safety top of mind
AstraZeneca, Daiichi Sankyo show off ADC portfolio with safety top of mind
Fierce Biotech
AstraZeneca
Daiichi Sankyo
antibody-drug conjugate
non-small cell lung cancer
Dato-DXd
Flag link:
AstraZeneca’s Fasenra meets primary endpoint in Phase III rare vasculitis trial
AstraZeneca’s Fasenra meets primary endpoint in Phase III rare vasculitis trial
Clinical Trials Arena
AstraZeneca
Fasenra
GSK
Nucala
eosinophilic granulomatosis with polyangiitis
clinical trials
Flag link:
AstraZeneca seeks to calm CEO speculation after shares drop
AstraZeneca seeks to calm CEO speculation after shares drop
Reuters
AstraZeneca
Pascal Soriot
Pharma CEOs
Flag link:
WCLC: Tagrisso's chemo combo shows edge, but AstraZeneca thinks monotherapy remains king in lung cancer
WCLC: Tagrisso's chemo combo shows edge, but AstraZeneca thinks monotherapy remains king in lung cancer
Fierce Pharma
AstraZeneca
Tagrisso
non-small cell lung cancer
Flag link:
AstraZeneca Signs AI-Powered Drug Discovery Pact with Verge
AstraZeneca Signs AI-Powered Drug Discovery Pact with Verge
BioSpace
AstraZeneca
artificial intelligence
drug discovery
Verge Genomics
Flag link:
The 10 highest value R&D projects in biopharma
The 10 highest value R&D projects in biopharma
Fierce Biotech
R&D
biotech
Merck
sotatercept
Daiichi Sankyo
AstraZeneca
Dato-DXd
Novo Nordisk
CagriSema
Eli Lilly
donanemab
Karuna Therapeutics
Zai Lab
KarXT
Moderna Therapeutics
mRNA-1647
Novartis
iptacopan
Madrigal Pharmaceuticals
resmetirom
Cytokinetics
aficamten
Roche
Chugai
tiragolumab
Flag link:
FDA blocks new use for AstraZeneca's Ultomiris
FDA blocks new use for AstraZeneca's Ultomiris
Pharmaphorum
AstraZeneca
Ultomiris
Soliris
FDA
NMOSD
Flag link:
AstraZeneca hopes to make clinical trial operations carbon-negative by 2030
AstraZeneca hopes to make clinical trial operations carbon-negative by 2030
Clinical Trials Arena
AstraZeneca
sustainability
environmental concerns
Flag link:
After AstraZeneca mRNA deal, CanSino eyes other production partnerships
After AstraZeneca mRNA deal, CanSino eyes other production partnerships
Fierce Pharma
CanSino
MRNA
AstraZeneca
vaccines
Flag link:
Biden administration lists 10 drugs for Medicare price negotiation
Biden administration lists 10 drugs for Medicare price negotiation
Medical Marketing and Media
Medicare
HHS
Pfizer
Bristol Myers Squibb
Eli Lilly
Boehringer Ingelheim
AstraZeneca
AbbVie
Novo Nordisk
JNJ
drug pricing
Flag link:
Abrysvo and Beyfortus Could Transform RSV Prophylaxis for Young Children in the US
Abrysvo and Beyfortus Could Transform RSV Prophylaxis for Young Children in the US
Clinical Trials Arena
Pfizer
AstraZeneca
Sanofi
Abrysvo
Beyfortus
RSV
Flag link:
AstraZeneca Latest to Sue Biden Administration Over IRA’s Drug Price Negotiations
AstraZeneca Latest to Sue Biden Administration Over IRA’s Drug Price Negotiations
BioSpace
AstraZeneca
legal
Joe Biden
drug pricing
Inflation Reduction Act
Flag link:
Zacks Industry Outlook Highlights Eli Lilly, J&J, Novo Nordisk, Novartis and AstraZeneca
Zacks Industry Outlook Highlights Eli Lilly, J&J, Novo Nordisk, Novartis and AstraZeneca
Yahoo/Zacks.com
earnings
Eli Lilly
JNJ
Novo Nordisk
Novartis
AstraZeneca
Flag link:
How an AstraZeneca exec is leading the charge in the next immuno-oncology era
How an AstraZeneca exec is leading the charge in the next immuno-oncology era
Pharma Voice
AstraZeneca
immuno-oncology
Flag link:
FDA warns AstraZeneca over false advertising of COPD drug
FDA warns AstraZeneca over false advertising of COPD drug
Beckers Hospital Review
AstraZeneca
COPD
FDA
Breztri Aerosphere
DTC advertising
Flag link:
The 10 drugs that CMS might wrangle into negotiations
The 10 drugs that CMS might wrangle into negotiations
Beckers Hospital Review
CMS
Medicare
drug pricing
Bristol Myers Squibb
Janssen
Merck
Pfizer
Amgen
Boehringer Ingelheim
Pharmacyclics
AstraZeneca
Astellas
GSK
Flag link:

Pages